SKIN: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-1,415	9,616
Share-based compensation	11,239	8,784
Amortization of intangible assets	13,513	6,801
Depreciation of property and equipment	3,204	2,567
Amortization of other assets	3,281	2,197
Amortization of debt issuance costs	2,621	1,640
Inventory write-down	3,643	2,478
Provision for estimated credit losses	1,933	1,577
Change in fair value of warrant liabilities	-349	-139
Gain on exchange and repurchases of convertible senior notes, net	18,089	18,089
Deferred income taxes	2,893	818
Other, net	-2,679	-3,998
Accounts receivable	-4,769	-2,281
Inventories	-11,114	-9,089
Prepaid expenses, other current assets, and income tax receivable	110	-568
Accounts payable, accrued expenses, and income tax payable	-7,117	-9,721
Other, net	6,162	3,827
Net cash provided by (used for) operating activities	22,289	12,642
Cash paid for intangible assets	3,617	2,560
Cash paid for property and equipment	164	137
Net cash used for investing activities	-3,781	-2,697
Repurchase of 2026 notes in connection with exchange	392,583	392,583
Issuance of 2028 notes in connection with exchange, net	237,686	238,302
Repurchase of 2026 notes	18,372	18,372
Payment of tax withholdings on vested stock awards	1,145	958
Net cash used for financing activities	-174,414	-173,611
Net change in cash, cash equivalents, and restricted cash	-155,906	-163,666
Effect of exchange rate changes on cash	5,240	-
Cash and cash equivalents at beginning of period	370,063	-
Cash and cash equivalents at end of period	219,397	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

SKIN: the cashflow